|

Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients

RECRUITINGSponsored by Leiden University Medical Center
Actively Recruiting
SponsorLeiden University Medical Center
Started2019-03-05
Est. completion2025-09-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05377957

Summary

PROQEM is a prospective cohort study among patients diagnosed with uveal melanoma to assess quality of life before and in the first five years after treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥18 years
* Clinical or pathological diagnosis of a melanoma of the choroid or ciliary body
* No signs of metastasis after staging procedures with at least an X-thorax, blood test and an ultrasound of the liver
* Treatment by brachytherapy, proton therapy or enucleation

Exclusion Criteria:

* None

Conditions2

CancerUveal Melanoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.